CD4 and melanoma: To determine how these CD4+Foxp3+IL-10+ cells affect the anti-metastatic effects of metformin, we injected C57BL/6J mice with anti-CD25 1 day prior, and 1 and 7 days after B16F10 melanoma inoculation (Figure 7E).